Pnc Financial Services Group, Inc. Lava Therapeutics Nv Transaction History

Pnc Financial Services Group, Inc.

  • $148 Billion
  • Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 65,000 shares of LVTX stock, worth $63,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,000
Previous 65,000 -0.0%
Holding current value
$63,050
Previous $107,000 41.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$1.4 - $2.6 $21,000 - $39,000
15,000 Added 30.0%
65,000 $131,000
Q4 2022

Feb 10, 2023
BUY
$3.37 - $7.31 $168,500 - $365,500
50,000 New
50,000 $175,000

Others Institutions Holding LVTX

# of Institutions
23
Shares Held
3.36M
Call Options Held
100
Put Options Held
200
View Full List

About LAVA Therapeutics NV

LVTX Quotes by TradingView
  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $25M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email